Position in BMY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$307,055
-$28,278 QoQ
Shares Held
5,329
-3.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
#1,866
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Aberdeen Wealth Management LLC holds $7,869,904 across 14 Drug Manufacturers - General names. BMY ranks #6 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
9,276 | $2,334,208 | |
| 2 | JNJ |
Johnson & Johnson
|
8,486 | $2,155,180 | |
| 3 | NVS |
Novartis AG
|
6,045 | $947,369 | |
| 4 | AMGN |
Amgen Inc
|
1,542 | $558,386 | |
| 5 | LLY |
ELI LILLY & Co
|
370 | $443,788 | |
| 6 | BMY |
Bristol Myers Squibb Co
This page
|
5,329 | $307,055 | |
| 7 | PFE |
Pfizer Inc
|
12,072 | $290,687 | |
| 8 | NVO |
Novo Nordisk A S
|
4,946 | $237,111 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $307,055 | 5,329 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $335,333 | 5,529 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $300,931 | 5,579 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $269,652 | 5,979 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $290,053 | 6,266 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $382,163 | 6,266 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $354,404 | 6,266 | Shares | Sole | 2025-02-21 | |
| 2024-09-30 | $333,050 | 6,437 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $287,346 | 6,919 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $375,217 | 6,919 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $355,013 | 6,919 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $430,598 | 7,419 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $480,840 | 7,519 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $519,755 | 7,499 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $539,553 | 7,499 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $533,103 | 7,499 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $577,423 | 7,499 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $576,863 | 7,899 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $492,502 | 7,899 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $466,200 | 7,879 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $572,112 | 8,562 | Shares | Sole | 2021-07-23 | |
| 2021-03-31 | $540,519 | 8,562 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $547,166 | 8,821 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $519,518 | 8,617 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $572,124 | 9,730 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $483,098 | 8,667 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||